<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DESMOPRESSIN ACETATE- desmopressin acetate spray </strong><br>Prasco Laboratories<br></p></div>
<h1>Desmopressin Acetate<br> Nasal Spray, 10 mcg per 0.1 mL</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Desmopressin Acetate Nasal Spray is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. It is chemically defined as follows:</p>
<p>Mol. wt. 1183.34<br>Empirical formula: C<span class="Sub">46</span>H<span class="Sub">64</span>N<span class="Sub">14</span>O<span class="Sub">12</span>S<span class="Sub">2</span>•C<span class="Sub">2</span>H<span class="Sub">4</span>O<span class="Sub">2</span>•3H<span class="Sub">2</span>O</p>
<p><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-01.jpg"></p>
<p>1-(3-mercaptopropionic acid)-8-D-arginine vasopressin monoacetate (salt) trihydrate.</p>
<p>Desmopressin Acetate Nasal Spray is provided as an aqueous solution for intranasal use.</p>
<p>Each mL contains:<br>Desmopressin acetate 0.1 mg<br>Sodium chloride 7.5 mg<br>Citric acid monohydrate 1.7 mg<br>Disodium phosphate dihydrate 3 mg<br>Benzalkonium chloride solution (50%) 0.2 mg</p>
<p>The Desmopressin Acetate Nasal Spray compression pump delivers 0.1 mL (10 mcg) of desmopressin acetate per spray.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Desmopressin acetate contains as active substance 1-(3-mercaptopropionic acid)-8-D-arginine vasopressin, which is a synthetic analogue of the natural hormone arginine vasopressin. One mL (0.1 mg) of intranasal desmopressin acetate has an antidiuretic activity of about 400 International Units (IU); 10 mcg of desmopressin acetate is equivalent to 40 IU. The change in structure of arginine vasopressin to desmopressin acetate has resulted in a decreased vasopressor action and decreased actions on visceral smooth muscle relative to the enhanced antiduretic activity, so that clinically effective antiduretic doses are usually below threshold levels for effects on vascular or visceral smooth muscle. </p>
<p>Desmopressin acetate administered intranasally has an antiduretic effect about one-tenth that of an equivalent dose administered by injection.</p>
<div class="Section" data-sectionCode="43682-4">
<a name="pharmacokinetics"></a><a name="section-3.1"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">Intranasal Desmopressin Acetate is absorbed from the nasal mucosa. Desmopressin Acetate exhibits a biphasic elimination profile, with half-lives of 7.8 and 75.5 minutes for the initial and terminal phases, respectively, in contrast to lysine vasopressin, which has initial and terminal phase half-lives of 2.5 and 14.5 minutes, respectively. Desmopressin Acetate is mainly excreted in the urine. A pharmacokinetic study conducted in healthy volunteers and patients with mild, moderate, and severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (n=24, 6 subjects each group) receiving single dose Desmopressin Acetate (2 mcg) injection demonstrated a difference in Desmopressin Acetate half-life. Terminal half-life significantly increased from 3 hours in normal healthy patients to 9 hours in patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>. [See<span class="Bold"><a href="#contraindications"> CONTRAINDICATIONS</a>.</span>]</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-4.1"></a><p></p>
<h2>Central Cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">Diabetes Insipidus</span></h2>
<p class="First">Desmopressin Acetate Nasal Spray is indicated as antidiuretic replacement therapy in the management of central cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span> and for management of the temporary <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span> and <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span> following head <span class="product-label-link" type="condition" conceptid="433633" conceptname="Late effect of superficial injury">trauma</span> or surgery in the pituitary region. It is ineffective for the treatment of <span class="product-label-link" type="condition" conceptid="438476" conceptname="Nephrogenic diabetes insipidus">nephrogenic diabetes insipidus</span>.</p>
<p>The use of Desmopressin Acetate Nasal Spray in patients with an established diagnosis will result in a reduction in urinary output with increase in urine <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> and a decrease in plasma <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span>. This will allow the resumption of a more normal life-style with decrease in <span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">urinary frequency</span> and <span class="product-label-link" type="condition" conceptid="40304526" conceptname="Nocturia">nocturia</span>.</p>
<p>There are reports of an occasional change in response with time, usually greater than 6 months. Some patients may show a decreased responsiveness, others a shortened duration of effect. There is no evidence this effect is due to the development of binding antibodies but may be due to a local inactivation of the peptide.</p>
<p>Patients are selected for therapy by establishing the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or the response to antidiuretic hormone. Continued response to intranasal desmopressin acetate can be monitored by urine volume and <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span>.</p>
<p>Desmopressin Acetate is also available as a solution for injection when the intranasal route may be compromised. These situations include <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal congestion</span> and blockage, <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">nasal discharge</span>, <span class="product-label-link" type="condition" conceptid="4028206" conceptname="Atrophy">atrophy</span> of nasal mucosa, and severe atrophic <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>. Intranasal delivery may also be inappropriate where there is an impaired level of consciousness. In addition, cranial surgical procedures, such as transsphenoidal hypophysectomy create situations where an alternative route of administration is needed as in cases of nasal packing or recovery from surgery.</p>
</div>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="contraindications"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Desmopressin Acetate Nasal Spray is contraindicated in individuals with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to desmopressin acetate or to any of the components of Desmopressin Acetate Nasal Spray.</p>
<p>Desmopressin Acetate is contraindicated in patients with moderate to severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (defined as a creatinine clearance below 50 mL/min). </p>
<p>Desmopressin Acetate is contraindicated in patients with <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> or a history of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="warnings"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<ol class="Arabic">
<li>For intranasal use only.</li>
<li>Desmopressin Acetate Nasal Spray should only be used in patients where orally administered formulations are not feasible.</li>
<li>Very rare cases of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> have been reported from world-wide postmarketing experience in patients treated with Desmopressin Acetate. Desmopressin Acetate is a potent antidiuretic which, when administered, may lead to <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span> and/or <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>. Unless properly diagnosed and treated <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> can be fatal. Therefore, fluid restriction is recommended and should be discussed with the patient and/or guardian. Careful medical supervision is required.</li>
<li>When Desmopressin Acetate Nasal Spray is administered, in particular in pediatric and geriatric patients, fluid intake should be adjusted downward in order to decrease the potential occurrence of <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span> and <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>. [See<span class="Bold"><a href="#P_peds"> PRECAUTIONS, Pediatric Use </a></span>and<span class="Bold"><a href="#P_ger"> Geriatric Use</a></span>.] All patients receiving Desmopressin Acetate therapy should be observed  for the following signs or symptoms associated with <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>: <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>/<span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, decreased serum sodium, <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span>, <span class="product-label-link" type="condition" conceptid="4061577" conceptname="Lethargy">lethargy</span>, <span class="product-label-link" type="condition" conceptid="4011527" conceptname="Spatial disorientation">disorientation</span>, depressed reflexes, loss appetite, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscle weakness</span>, <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">muscle spasms</span> or <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">cramps</span> and abnormal mental status such as <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, decreased consciousness and <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>. Severe symptoms may include one or a combination of the following: <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizure</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span> and/or <span class="product-label-link" type="condition" conceptid="317109" conceptname="Respiratory arrest">respiratory arrest</span>. Particular attention should be paid to the possibility of the rare occurrence of an extreme decrease in plasma <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> that may result in <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">seizures</span> which could lead to <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>.</li>
<li>Desmopressin Acetate should be used with caution in patients with habitual or <span class="product-label-link" type="condition" conceptid="4049477" conceptname="Psychogenic polydipsia">psychogenic polydipsia</span> who may be more likely to drink excessive amounts of water, putting them at greater risk of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Desmopressin Acetate Nasal Spray at high dosage has infrequently produced a slight elevation of blood pressure, which disappeared with a reduction in dosage. The drug should be used with caution in patients with coronary artery insufficiency and/or hypertensive cardiovascular disease because of possible <span class="product-label-link" type="condition" conceptid="141693" conceptname="Elevated blood-pressure reading without diagnosis of hypertension">rise in blood pressure</span>.</p>
<p>Desmopressin Acetate Nasal Spray should be used with caution in patients with conditions associated with fluid and <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte imbalance</span>, such as <span class="product-label-link" type="condition" conceptid="441267" conceptname="Cystic fibrosis">cystic fibrosis</span>, <span class="product-label-link" type="condition" conceptid="316139" conceptname="Heart failure">heart failure</span> and <span class="product-label-link" type="condition" conceptid="198124" conceptname="Kidney disease">renal disorders</span> because these patients are prone to <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>. </p>
<p>Rare severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span> have been reported with desmopressin acetate. <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylaxis</span> has been reported rarely with intravenous administration and intranasal administration of desmopressin acetate.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.2"></a><p></p>
<h2>Central Cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">Diabetes Insipidus</span></h2>
<p class="First">Since Desmopressin Acetate is used intranasally, changes in the nasal mucosa such as <span class="product-label-link" type="condition" conceptid="4050007" conceptname="Scar">scarring</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, or other disease may cause erratic, unreliable absorption in which case intranasal Desmopressin Acetate should not be used. For such situations, desmopressin acetate injection should be considered.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.3"></a><p></p>
<h2>Information for Patients</h2>
<p class="First"><span class="Bold">Ensure that in children administration is under adult supervision in order to control the dose intake. </span>Patients should be informed that the Desmopressin Acetate Nasal Spray bottle accurately delivers 50 sprays of 10 mcg each. Any solution remaining after 50 sprays should be discarded since the amount delivered thereafter may be substantially less than 10 mcg of drug. No attempt should be made to transfer remaining solution to another bottle. Patients should be instructed to read accompanying directions on use of the spray pump carefully before use.</p>
<p>Fluid intake should be adjusted downward based upon discussion with the physician.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-7.4"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Laboratory tests for following the patient with central cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span> or post-surgical or head <span class="product-label-link" type="condition" conceptid="433633" conceptname="Late effect of superficial injury">trauma</span>-related <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span> and <span class="product-label-link" type="condition" conceptid="432454" conceptname="Excessive thirst">polydipsia</span> include urine volume and <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span>. In some cases plasma <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> measurements may be required. </p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.5"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Although the pressor activity of Desmopressin Acetate is very low compared to the antidiuretic activity, use of large doses of intranasal Desmopressin Acetate with other pressor agents should only be done with careful patient monitoring. The concomitant administration of drugs that may increase the risk of <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span> with <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, NSAIDs, lamotrigine and carbamazepine) should be performed with caution.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.6"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Studies with Desmopressin Acetate have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.7"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-7.7.1"></a><p></p>
<h3>Category B</h3>
<p class="First">Fertility studies have not been done. Teratology studies in rats and rabbits at doses from 0.05 to 10 mcg/kg/day (approximately 0.1 times the maximum systemic human exposure in rats and up to 38 times the maximum systemic human exposure in rabbits based on surface area, mg/m<span class="Sup">2</span>) revealed no harm to the fetus due to desmopressin acetate. There are, however, no adequate and well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
<p>Several publications of desmopressin acetate's use in the management of <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span> during pregnancy are available; these include a few anecdotal reports of congenital anomalies and low birth weight babies. However, no causal connection between these events and desmopressin acetate has been established. A fifteen year Swedish epidemiologic study of the use of desmopressin acetate in pregnant women with <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span> found the rate of <span class="product-label-link" type="condition" conceptid="4029540" conceptname="Congenital anomaly">birth defects</span> to be no greater than that in the general population. However, the statistical power of this study is low. As opposed to preparations containing natural hormones, desmopressin acetate in antidiuretic doses has no uterotonic action and the physician will have to weigh the therapeutic advantages against the possible risks in each case.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.8"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">There have been no controlled studies in nursing mothers. A single study in postpartum women demonstrated a marked change in plasma, but little if any change in assayable desmopressin acetate in breast milk following an intranasal dose of 10 mcg. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when desmopressin acetate is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="P_peds"></a><a name="section-7.9"></a><p></p>
<h2>Pediatric Use</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-7.9.1"></a><p></p>
<h3>Central Cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">Diabetes Insipidus</span></h3>
<p class="First">Desmopressin Acetate Nasal Spray has been used in children with <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">diabetes insipidus</span>. Use in infants and children will require careful fluid intake restriction to prevent possible <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> and <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span>. (See<span class="Bold"><a href="#warnings"> WARNINGS</a></span>.) The dose must be individually adjusted to the patient with attention in the very young to the danger of an extreme decrease in plasma <span class="product-label-link" type="condition" conceptid="4197115" conceptname="Osmotic pressure">osmolality</span> with resulting <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>. Dose should start at 0.05 mL or less. Since the spray cannot deliver less than 0.1 mL (10 mcg), smaller doses should be administered using the rhinal tube delivery system. Do not use the nasal spray in pediatric patients requiring less than 0.1 mL (10 mcg) per dose.</p>
</div>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="P_ger"></a><a name="section-7.10"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of Desmopressin Acetate Nasal Spray did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at a low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy.</p>
<p>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Desmopressin Acetate is contraindicated in patients with moderate to severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> (defines as a creatinine clearance below 50 mL/min). [See<span class="Bold"><a href="#pharmacokinetics"> CLINICAL PHARMACOLOGY, Human Pharmacokinetics </a></span>and<span class="Bold"><a href="#contraindications"> CONTRAINDICATIONS</a>.</span>]</p>
<p>Use of Desmopressin Acetate Nasal Spray in geriatric patients will require careful fluid intake restriction to prevent possible <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> and <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span>. [See<span class="Bold"><a href="#warnings"> WARNINGS</a>.</span>]</p>
<p>There are reports of an occasional change in response with time, usually greater than 6 months. Some patients may show a decreased responsiveness, others a shortened duration of effect. There is no evidence this is due to the development of binding antibodies but may be due to a local inactivation of the peptide.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Infrequently, high dosages of intranasal Desmopressin Acetate have produced transient <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> and <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>. <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">Nasal congestion</span>, <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span> and <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> have also been reported occasionally along with mild <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span>. These symptoms disappeared with reduction in dosage. <span class="product-label-link" type="condition" conceptid="318556" conceptname="Epistaxis">Nosebleed</span>, <span class="product-label-link" type="condition" conceptid="26711" conceptname="Chronic pharyngitis">sore throat</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> and <span class="product-label-link" type="condition" conceptid="4181583" conceptname="Upper respiratory infection">upper respiratory infections</span> have also been reported.</p>
<p>The following table lists the percent of patients having adverse experiences without regard to relationship to study drug from the pooled pivotal study data for <span class="product-label-link" type="condition" conceptid="193874" conceptname="Nocturnal enuresis">nocturnal enuresis</span>.</p>
<table width="75%">
<col align="left" valign="top" width="31%">
<col align="center" valign="top" width="25%">
<col align="center" valign="top" width="22%">
<col align="center" valign="top" width="22%">
<thead><tr class="First Last">
<th align="left" valign="bottom">ADVERSE REACTION</th>
<th align="center" valign="middle">PLACEBO<br>(N=59)<br>%</th>
<th align="center">Desmopressin acetate 20 mcg<br>(N=60)<br>%</th>
<th align="center">Desmopressin acetate 40 mcg<br>(N=61)<br>%</th>
</tr></thead>
<tbody>
<tr class="First">
<td align="left">BODY AS A WHOLE</td>
<td align="center"></td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal Pain</span></td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">Asthenia</span></td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Chills</span></td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">NERVOUS SYSTEM</td>
<td align="center"></td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span> </td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">RESPIRATORY SYSTEM</td>
<td align="center"></td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="318556" conceptname="Epistaxis">Epistaxis</span></td>
<td align="center">2</td>
<td align="center">3</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  Nostril <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span></td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span></td>
<td align="center">2</td>
<td align="center">8</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">DIGESTIVE SYSTEM</td>
<td align="center"></td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">Gastrointestinal Disorder</span> </td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">SPECIAL SENSES</td>
<td align="center"></td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">Conjunctivitis</span></td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span> Eyes</td>
<td align="center">0</td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr class="Last">
<td align="left">  Lachrymation Disorder</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
</tbody>
</table>
<div class="Section" data-sectionCode="42229-5">
<a name="section-8.1"></a><p></p>
<h2>Post Marketing</h2>
<p class="First">There have been rare reports of <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span> <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> associated with concomitant use with the following medications: oxybutinin and imipramine.</p>
<p>See<span class="Bold"><a href="#warnings"> WARNINGS </a></span>for the possibility of <span class="product-label-link" type="condition" conceptid="4215499" conceptname="Water intoxication syndrome">water intoxication</span> and <span class="product-label-link" type="condition" conceptid="4232311" conceptname="Hyponatremia">hyponatremia</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Signs of overdosage may include <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, continuing <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, problems with passing urine and rapid <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span> due to <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>. [See<span class="Bold"><a href="#warnings"> WARNINGS</a>.</span>] In case of overdosage, the dose should be reduced, frequency of administration decreased, or the drug withdrawn according to the severity of the condition. There is no known specific antidote for desmopressin acetate or Desmopressin Acetate Nasal Spray.</p>
<p>An oral LD<span class="Sub">50</span> has not been established. An intravenous dose of 2 mg/kg in mice demonstrated no effect.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-10.1"></a><p></p>
<h2>Central Cranial <span class="product-label-link" type="condition" conceptid="30968" conceptname="Diabetes insipidus">Diabetes Insipidus</span></h2>
<p class="First">Desmopressin Acetate Nasal Spray dosage must be determined for each individual patient and adjusted according to the diurnal pattern of response. Response should be estimated by two parameters: adequate duration of sleep and adequate, not excessive, water turnover. Patients with <span class="product-label-link" type="condition" conceptid="4195085" conceptname="Nasal congestion">nasal congestion</span> and blockage have often responded well to intranasal Desmopressin Acetate. The usual dosage range in adults is 0.1 mL (10 mcg) to 0.4 mL (40 mcg) daily, either as a single dose or divided into two or three doses. Most adults require 0.2 mL (20 mcg) daily in two divided doses.</p>
<p>The morning and evening doses should be separately adjusted for an adequate diurnal rhythm of water turnover. For children aged 3 months to 12 years, the usual dosage range is 0.05 mL (5 mcg) to 0.3 mL (30 mcg) daily, either as a single dose or divided into two doses. About 1/4 to 1/3 of patients can be controlled by a single daily dose of Desmopressin Acetate administered intranasally. Fluid restriction should be observed. [See<span class="Bold"><a href="#warnings"> WARNINGS</a>,<a href="#P_peds"> PRECAUTIONS, Pediatric Use </a></span>and<span class="Bold"><a href="#P_ger"> Geriatric Use</a></span>.]</p>
<p>The nasal spray pump can only deliver doses of 0.1 mL (10 mcg) or multiples of 0.1 mL. If doses other than these are required, the rhinal tube delivery system may be used.</p>
<p>The spray pump must be primed prior to the first use. To prime pump, press down four times. The bottle will now deliver 10 mcg of drug per spray. Discard Desmopressin Acetate Nasal Spray after 50 sprays since the amount delivered thereafter per spray may be substantially less than 10 mcg of drug.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Desmopressin Acetate Nasal Spray is available as a 5 mL bottle with spray pump delivering 50 sprays of 10 mcg (NDC 66993-025-01). </p>
<div class="Section" data-sectionCode="44425-7">
<a name="section-11.1"></a><p></p>
<p class="First">Store at Controlled Room Temperature 20 to 25°C (68 to 77°F) [see USP]. STORE BOTTLE IN UPRIGHT POSITION.</p>
<p><span class="Bold">Keep out of the reach of children.</span><br>U.S. Pat. Nos. 5,500,413, 5,596,078, and 5,674,850</p>
<p>Toll free number for providers and patients to call with questions: <br> 1-888-FERRING (1-888-337-7464)</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-12"></a><p></p>
<p class="First">Manufactured for:<br>Prasco Laboratories<br>Mason, OH 45040 USA</p>
<p>6475-02<br>REV. 05/2014</p>
</div>
<div class="Section" data-sectionCode="42231-1">
<a name="section-13"></a><p></p>
<p class="First"><span class="Bold">Instructions for Use<br>Desmopressin Acetate <br>Nasal Spray, 10 mcg per 0.1 mL<br>For Intranasal Use Only</span></p>
<p>Read these instructions before using Desmopressin Acetate nasal spray, and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.</p>
<p><span class="Bold">Children should be helped by an adult when using Desmopressin Acetate nasal spray, to make sure the right amount of medicine is used.</span></p>
<p><span class="Bold">The parts of your Desmopressin Acetate nasal spray pump </span>(See<a href="#figA"> Figure A</a>)<span class="Bold">:</span></p>
<a name="figA"></a><table class="Noautorules" width="100%">
<col align="center" valign="top" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Figure A" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-02.jpg"></td></tr>
<tr><td align="center"><span class="Bold">Figure A</span></td></tr>
</tbody>
</table>
<p><span class="Bold">Priming your Desmopressin Acetate nasal spray:</span></p>
<p>Your Desmopressin Acetate nasal spray pump must be primed before you use it for the first time.</p>
<ul class="Disc"><li>Remove the protective cap (See<a href="#figB"> Figure B</a>).</li></ul>
<a name="figB"></a><table class="Noautorules" width="100%">
<col align="center" valign="top" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Figure B" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-03.jpg"></td></tr>
<tr><td align="center"><span class="Bold">Figure B</span></td></tr>
</tbody>
</table>
<ul class="Disc"><li>Press down on the shoulders at the top of your Desmopressin Acetate nasal spray pump 4 times. Hold the spray tip away from your face and eyes (See<a href="#figC"> Figure C</a>).</li></ul>
<a name="figC"></a><table class="Noautorules" width="100%">
<col align="center" valign="top" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Figure C" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-04.jpg"></td></tr>
<tr><td align="center"><span class="Bold">Figure C</span></td></tr>
</tbody>
</table>
<ul class="Disc"><li>After your Desmopressin Acetate nasal spray pump is primed, it will spray 10 micrograms (1 dose) of medicine each time it is pressed. </li></ul>
<p><span class="Bold">Using your Desmopressin Acetate nasal spray:</span></p>
<p><span class="Bold">Step 1. </span>Remove the protective cap.</p>
<p><span class="Bold">Step 2. </span>To make sure you get the right dose of medicine tilt your Desmopressin Acetate nasal spray pump so the dip tube inside the bottle draws the medicine up from the deepest part of the medicine inside the bottle (See<a href="#figD"> Figures D </a>and<a href="#figD"> E</a>).</p>
<a name="figD"></a><table class="Noautorules" width="100%">
<col align="center" valign="bottom" width="50%">
<col align="center" valign="bottom" width="50%">
<tbody class="Headless">
<tr>
<td align="center"><img alt="Figure D" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-05.jpg"></td>
<td align="center"><img alt="Figure E" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-06.jpg"></td>
</tr>
<tr>
<td align="center"><span class="Bold">Figure D</span></td>
<td align="center"><span class="Bold">Figure E</span></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Step 3. </span>Put the spray nozzle tip of your Desmopressin Acetate nasal spray into your nostril and press the spray pump 1 time for 1 dose. (See<a href="#figF"> Figure F</a>). If 2 doses are prescribed, spray each nostril 1 time.</p>
<a name="figF"></a><table class="Noautorules" width="100%">
<col align="center" valign="top" width="100%">
<tbody class="Headless">
<tr><td align="center"><img alt="Figure F" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-07.jpg"></td></tr>
<tr><td align="center"><span class="Bold">Figure F</span></td></tr>
</tbody>
</table>
<p><span class="Bold">Step 4. </span>Put the protective cap back on the spray nozzle tip when you finish using your Desmopressin Acetate nasal spray. </p>
<p><span class="Bold">Keeping track of your nasal sprays:</span></p>
<ul class="Disc"><li>Use the check-off chart to help you keep track of your Desmopressin Acetate nasal sprays used (See<a href="#figG"> Figure G</a>). </li></ul>
<a name="figG"></a><table class="Noautorules" width="100%">
<col align="center" valign="top" width="100%">
<tbody class="Headless">
<tr><td align="center"><span class="Bold">Desmopressin Acetate nasal spray<br>50-Spray Check-off Chart</span></td></tr>
<tr><td align="center"><img alt="Figure G" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-08.jpg"></td></tr>
<tr><td align="center"><span class="Bold">Figure G</span></td></tr>
</tbody>
</table>
<ul class="Disc">
<li>Keep this chart with your Desmopressin Acetate nasal spray or put it someplace where you can easily get it.</li>
<li>Check off number 1 on the chart with your first dose of Desmopressin Acetate nasal spray. Check off the numbers after each use of your Desmopressin Acetate nasal spray. If your healthcare provider prescribed a 2-spray dose, then 2 numbers should be checked off.</li>
<li>Your Desmopressin Acetate nasal spray holds 50 sprays with the right amount of medicine in each spray. </li>
<li>If any medicine is left in your Desmopressin Acetate nasal spray after 50 sprays,<span class="Bold"> do not </span>use it. You may not get the right amount of medicine. </li>
<li>Throw away your Desmopressin Acetate nasal spray after 50 sprays.</li>
<li>
<span class="Bold">Do not </span>count the priming sprays. Your Desmopressin Acetate nasal spray has been filled with extra medicine for your priming sprays.</li>
<li>
<span class="Bold">Do not </span>try to remove any medicine from your Desmopressin Acetate nasal spray pump and place it in another bottle.</li>
</ul>
<p><span class="Bold">How should I store Desmopressin Acetate nasal spray?</span></p>
<ul class="Disc">
<li>Store Desmopressin Acetate nasal spray at room temperature between 68°F to 77°F (20°C to 25°C).</li>
<li>Store Desmopressin Acetate nasal spray standing upright. </li>
</ul>
<p><span class="Bold">This Instructions for Use has been approved by the U.S. Food and Drug Administration.</span></p>
<p>Manufactured for:<br>Prasco Laboratories<br>Mason, OH 45040 USA</p>
<p>6475-02<br>REV. 05/2014</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 5 mL Bottle Carton</h1>
<p class="First"><span class="Bold">NDC 66993-025-01</span></p>
<p><span class="Bold">PRASCO</span></p>
<p><span class="Bold">Desmopressin<br>Acetate</span></p>
<p>Nasal Spray</p>
<p>10 mcg per 0.1 mL</p>
<p><span class="Bold">Rx Only</span></p>
<p>5 mL<br>(50 sprays)</p>
<p><span class="Bold">Attention Pharmacist-</span><br>detach patient's<br>instructions from<br>package insert and<br>dispense with spray pump.</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 5 mL Bottle Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c9e4aedb-27d6-4499-9245-93937d3a375f&amp;name=desmopressin-09.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DESMOPRESSIN ACETATE 		
					</strong><br><span class="contentTableReg">desmopressin acetate spray</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66993-025</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">NASAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DESMOPRESSIN ACETATE</strong> (DESMOPRESSIN) </td>
<td class="formItem">DESMOPRESSIN ACETATE</td>
<td class="formItem">10 ug  in 0.1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CITRIC ACID MONOHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM PHOSPHATE, DIBASIC, DIHYDRATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66993-025-01</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 BOTTLE, PUMP; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA authorized generic</td>
<td class="formItem">NDA021333</td>
<td class="formItem">01/01/2014</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Prasco Laboratories
							(065969375)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Ferring Pharmaceuticals Inc. (103722955)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Ferring GmbH</td>
<td class="formItem"></td>
<td class="formItem">328609615</td>
<td class="formItem">MANUFACTURE(66993-025)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>73f4ef96-b08d-43ee-9ef2-fc99894c2c00</div>
<div>Set id: c9e4aedb-27d6-4499-9245-93937d3a375f</div>
<div>Version: 6</div>
<div>Effective Time: 20150504</div>
</div>
</div> <div class="DistributorName">Prasco Laboratories</div></p>
</body></html>
